Publications by authors named "Femke deRuyck"
Article Synopsis
- The study examined the epidemiology, management, and economic impact of myasthenia gravis using data from about 12 million people in Italy from 2011 to 2018.
- It found that the prevalence of myasthenia gravis in 2018 ranged from 13.5 to 29.3 cases per 100,000 people, with a population estimate of 8,190 to 17,728 affected individuals.
- Treatment indications revealed high usage of pyridostigmine (84%) and corticosteroids (54%), with healthcare costs for myasthenia gravis patients being four times greater than the general population, significantly increasing for those experiencing exacerbations.
